期刊文献+

斑马鱼在新药发现中的应用 被引量:15

Zebrafish in drug discovery
原文传递
导出
摘要 在过去20年里,斑马鱼已成为一种重要的模式脊椎动物,在发育、遗传、免疫、肿瘤和毒理等诸多研究领域中被广泛应用。近年来,斑马鱼作为活体模型越来越多地应用于某些生物学过程的药物筛选。通过斑马鱼初步筛选,在药物研发初期可确定化合物的生物学活性、毒性以及副作用等。最近的研究还发现,斑马鱼不仅用于新药筛选,还可用于药物结构的优化。本文重点介绍斑马鱼在新药发现中的应用。 Zebrafish has become an important model organism for the study of development,genetics,immunity,cancer and toxicity.In the past 20 years,the zebrafish has also been used to determine the bioactivity,toxicity,and off-target side effects of the lead compounds for drug discovery.A recent study has demonstrated that the zebra?sh is an effective model not only for drug screening but also for drug optimization.This review summarizes recent progress in drug discovery including identification and validation of novel drug targets,and screening for new therapeutic compounds.
出处 《生命科学》 CSCD 北大核心 2011年第3期273-278,共6页 Chinese Bulletin of Life Sciences
基金 国家重点基础研究发展计划("973"项目)(2007CB947100)
关键词 斑马鱼 新药发现 疾病模型 zebrafish drug discovery disease model
  • 相关文献

参考文献40

  • 1Zon LI, Bowman TV. Swimming into the future of drug discovery: in vivo chemical screens in zebrafish. ACS Chem Biol, 2010, 5(2): 159-61.
  • 2Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov, 2005, 4(1): 35-44.
  • 3Crawford AD, Esguerra CV, de Witte PA. Fishing for drugsfrom nature: Zebrafish as a technology platform for natural oroduct discovery. Planta Med. 2008.74(6): 624-32.
  • 4Rubinstein AL. Zebrafish: From disease modeling to drug discovery. Curr Opin Drug Discov Devel, 2003, 6(2): 218-23.
  • 5Tiefenbach J, Moll PR, Nelson MR, et al. A live zebrafish- based screening system for human nuclear receptor ligand and cofactor discovery. PLoS One, 2010, 5(3): e9797.
  • 6Sehnert A J, Stainier DY. A window to the heart: Can zebrafish mutants help us understand heart disease in humans? Trends Genet, 2002, 18(10): 491-4.
  • 7Sachidanandan C, Yeh JR, Peterson QP, et al. Identification of a novel retinoid by small molecule screening with zebrafish embryos. PLoS ONE, 2008, 3(4): e1947.
  • 8Murphey RD, Stern HM, Straub CT, et al. A chemical genetic screen for cell cycle inhibitors in Zebrafish embryos. Chem Biol Drug Des, 2006, 68(4): 213-9.
  • 9Parng C, Seng WL, Semino C, et al. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol, 2002, 1(1 Pt l): 41-8.
  • 10Raghunath M, Wong YS, Farooq M, et al. Pharmacologically induced angiogenesis in transgenic zebrafish. Biochem Biophys Res Commun, 2009, 378(4): 766-71.

二级参考文献39

  • 1杨景峰,董武,曹颖霞,王思珍.TCDD诱发斑马鱼胚胎shh基因表达降低及其对下颌发育的影响[J].Zoological Research,2005,26(5):506-512. 被引量:1
  • 2Mochan T A, Venere M, DiTullio R A Jr, et al. 53BP1, an activator of ATM in response to DNA damage[J]. DNA Repair(Amst), 2004,3(8-9):945-952.
  • 3Stucki M, Jackson S P. MDC1/NFBD1:A key regulator of the DNA damage response in higher eukaryotes[J]. DNA Repair(Amst), 2004, 3(8-9):953-957.
  • 4Chini C C, Chen J. Claspin, a regulator of CHK2 in DNA replication stress pathway[J]. DNA Repair(Amst), 2004,3(8-9):1033-1037.
  • 5Bartek J, Lukas J. Mammalian Gl-and S-phase checkpoints in response to DNA damage[J]. Cell Biol, 2001,13(6):738-747.
  • 6Kastan M B, Lim D S. The many substrates and functions of ATM [J]. Mol Cell Biol, 20003(3):179-186.
  • 7Wahl G M, Cart A M. The evolution of diverse biological responses to DNA damage: insights from yeast and p53 [J]. Nature Cell Biol, 2001,3(12):E277-E286.
  • 8Craig A, Scott M, Burch L, et al. Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain [J]. EMBO Rep, 2003,4(8):787-792.
  • 9Shiloh Y. ATM and related protein kinases: safeguarding genome integrity[J]. Nature Rev Cancer, 2003,3(3):155-168.
  • 10Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase [J]. Mol Cell Biol, 2004,5(10):792-804.

共引文献48

同被引文献190

引证文献15

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部